Active substances
Calcium chloride + Dextrose + Potassium chloride + Sodium chloride
- SFDA 3
- US FDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DEXTROSE ,RINGER | 55,8.60,0.30,0.33 g/ml,g/ml,g/ml,g/ml | Solution for injection · Intravenous use | 1 Bag | SAR 5.65 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| DEXTROSE ,RINGER | 55,8.60,0.30,0.33 g/ml,g/ml,g/ml,g/ml | Solution for injection · Intravenous use | 1 Bag | SAR 9.25 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| DEXTROSE ,RINGER | 55,8.60,0.30,0.33 g/ml,g/ml,g/ml,g/ml | Solution for injection · Intravenous use | 1 Bottle | SAR 11.40 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANESTHESIA-SUPPORTIVE AGENTS/ FLUID RESUSCITATION (UNCONTROLLED BLEEDING); CENTRAL DIABETES INSIPIDUS; FLUIDS AND VOLUME EXPANDERS-MAINTENANCE FLUIDS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;5GM/100ML;30MG/100ML;860MG/100ML | injectable · injection | BAXTER HLTHCARE | Discontinued | 23 Mar 1971 |
| DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;5GM/100ML;30MG/100ML;860MG/100ML | injectable · injection | B BRAUN | Discontinued | 28 Aug 1979 |
| DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;5GM/100ML;30MG/100ML;860MG/100ML | injectable · injection | HOSPIRA | Discontinued | 15 Jan 1980 |
| DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER | 33MG/100ML;5GM/100ML;30MG/100ML;860MG/100ML | injectable · injection | B BRAUN | Discontinued | 17 Apr 1992 |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.